查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944901

ECMO耗材市場：按產品、支援模式、應用和最終用戶分類，全球預測，2026-2032年

ECMO Consumables Market by Product, Mode Of Support, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

ECMO耗材市場預計到2025年將達到5.5484億美元，到2026年將成長到5.9441億美元，到2032年將達到9.1037億美元，年複合成長率為7.33%。

關鍵市場統計數據
基準年 2025 5.5484億美元
預計年份：2026年 5.9441億美元
預測年份 2032 9.1037億美元
複合年成長率 (%) 7.33%

ECMO耗材權威架構明確了臨床依賴、關鍵供應鏈問題以及策略性相關人員的採購決策促進因素。

體外膜氧合（ECMO）耗材處於急性臨床照護和複雜的醫療設備供應鏈之間的關鍵環節。這些耗材是生命支持迴路的必需品，其可用性、設計和監管狀態直接影響心臟和呼吸支持的臨床結果。臨床醫生、醫院採購團隊和醫療設備負責人越來越認知到，耗材並非簡單的可互換商品，而是影響治療效果、病人安全和總醫療成本的關鍵組成部分。

材料技術、互通性和供應鏈模式的進步如何重塑體外膜氧合（ECMO）耗材的臨床應用和採購重點

體外膜氧合（ECMO）耗材領域正經歷變革性的轉變，這主要得益於技術改進、臨床通訊協定的不斷改進以及供應鏈的調整。聚合物化學和表面處理技術的進步降低了血栓形成傾向，提高了預充效率，使臨床醫生能夠延長安全運作並簡化迴路組裝。同時，緊湊型感測器套件和標準化連接器的整合提高了互通性，減輕了灌注團隊的認知和操作負擔，並實現了在緊急情況下的快速部署。

近期美國關稅調整對體外膜氧合（ECMO）耗材產業的籌資策略、供應韌性和製造商在地化選擇的影響

關稅和貿易政策環境會對體外膜氧合（ECMO）耗材的籌資策略產生重大影響，尤其是那些製造地集中的組件。美國近期調整關稅後，進口組件的成本核算更加嚴格，促使醫療機構和經銷商重新評估其供應商組合，並在條件允許的情況下加快本地化進程。這些政策訊號也活性化製造商和監管機構就替代供應商的資格認證以及確保雙重採購途徑展開對話。

多維細分分析揭示了產品類別、臨床應用、支援模式和最終用戶類型如何影響耗材選擇和供應策略。

細分市場層面的趨勢揭示了不同產品類型、病患小組、支持方式和最終用戶類型所面臨的獨特促進因素和限制因素，這些因素塑造了需求特徵和採購行為。產品細分涵蓋插管、熱交換器、氧合器、泵頭和管路組件，其中泵頭類別又細分為離心式幫浦頭和滾壓泵頭。每類產品都需要不同的檢驗、庫存策略和臨床培訓。成人、新生兒和兒童等不同應用群體對產品的尺寸、流速和血液接觸材料提出了獨特的要求，從而影響了產品型號的複雜性和滅菌通訊協定。

區域在製造、監管協調和分銷方面的策略重點將影響全球醫療保健生態系統的准入和臨床應用。

區域趨勢顯著影響體外膜氧合（ECMO）耗材的製造地、監管路徑和分銷模式，從而為銷售團隊制定了明確的策略重點。在美洲，集中式醫院系統和區域採購組織傾向於簽訂長期契約，並強調成人護理的擴充性，同時透過有針對性的分銷網路為新生兒和兒童專科中心提供支援。在歐洲、中東和非洲地區（EMEA），由於法規結構和報銷環境的差異，製造商需要根據當地情況客製化監管文件和註冊策略，尤其要關注當地的滅菌方法和標籤規範。

關鍵的競爭和合作夥伴趨勢正在透過臨床整合、售後服務和強大的分銷模式來塑造差異化優勢。

ECMO耗材供應商之間的競爭日益受到創新組合、服務模式和策略夥伴關係關係的影響，而不再僅限於產品價格。主要企業正致力於材料改進、連接器標準化和整合監控功能，以提升臨床易用性並減少操作失誤。同時，各企業也正在投資現場培訓專案、虛擬模擬模組和臨床顧問委員會，以推動產品應用並建立值得信賴的使用者群體。

製造商和醫療保健系統可採取的切實可行的策略重點，以提高體外膜氧合（ECMO）耗材市場的韌性、臨床應用率和收入永續性

產業領導者應採取一套平衡的戰術性和策略措施，以確保其在體外膜氧合（ECMO）耗材領域的長期地位。首先，實施雙源生產策略，並在監管和經濟條件有利於在地化的地區投資本地生產。這有助於降低關稅和物流衝擊帶來的風險，並縮短補貨週期。其次，在產品設計中優先考慮人因工程和互通性，確保設備能夠無縫整合到不同的灌注流程中。這有助於減輕培訓負擔，並減少操作流程的差異。

結合專家訪談、設備檢驗和供應鏈分析的嚴謹混合調查方法，確保了可靠且可操作的策略洞察。

本研究採用混合方法，結合了對關鍵相關人員的訪談、針對特定設備的分析以及對二級資訊來源的檢驗，以得出可靠的循證結論。主要輸入包括對循環系統、重症監護專家、醫院採購人員和監管專家的結構化訪談，以了解當地的優先事項和營運限制。設備層面的評估包括材料評估、連接器相容性審查和可用性測試，以比較不同代表性耗材類別之間的性能特徵。

本文綜合分析了各項策略需求，闡述了臨床表現、供應韌性和商業化策略如何決定體外膜氧合（ECMO）耗材的領先地位。

總之，ECMO耗材是現代重症監護流程的核心，需要製造商、經銷商和醫療系統協同應對，以滿足不斷變化的臨床、監管和物流需求。技術進步和互通性標準的提升正在提高臨床應用價值，而關稅和貿易趨勢正在重塑籌資策略和區域生產重點。針對不同產品類型、目標患者群體、支持模式和最終用戶類別的具體考量，凸顯了有針對性的證據生成和差異化市場推廣模式的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 ECMO耗材市場：依產品分類

  • 套管
  • 熱交換器
  • 氧合設備
  • 泵浦頭
    • 離心式幫浦泵頭
    • 滾筒泵頭
  • 管集

第9章 以支援方式分類的體外膜氧合（ECMO）耗材市場

  • 靜脈-動脈體外膜氧合（ECMO）
  • 靜脈-靜脈體外膜氧合（VV-ECMO）

第10章 ECMO耗材市場：依應用領域分類

  • 成人版
  • 新生
  • 兒童

第11章 ECMO耗材市場（依最終用戶分類）

  • 醫院
    • 公立醫院
      • 大學醫院
      • 社區醫院
    • 私立醫院
  • 專科診所

第12章 ECMO耗材市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 ECMO耗材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國體外膜氧合（ECMO）耗材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國體外膜氧合（ECMO）耗材市場

第16章 中國體外膜氧合（ECMO）耗材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Braile Biomedica
  • Chalice Medical Ltd.
  • Changzheng Medical Co., Ltd.
  • Chinabridge（Shenzhen）Medical Technology Co., Ltd.
  • CytoSorbents Corporation
  • Edwards Lifesciences Corporation
  • Eurosets Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • LivaNova PLC
  • MAQUET GmbH
  • MC3 Cardiopulmonary
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Neotech Products, Inc.
  • Nihon Kohden Corporation
  • Nipro Corporation
  • Spectrum Medical（UK）Limited
  • Terumo Corporation
  • ZOLL Medical Corporation
Product Code: MRR-F847BD9C7499

The ECMO Consumables Market was valued at USD 554.84 million in 2025 and is projected to grow to USD 594.41 million in 2026, with a CAGR of 7.33%, reaching USD 910.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 554.84 million
Estimated Year [2026] USD 594.41 million
Forecast Year [2032] USD 910.37 million
CAGR (%) 7.33%

An authoritative framing of ECMO consumables that clarifies clinical dependencies, supply chain imperatives, and procurement decision drivers for strategic stakeholders

Extracorporeal membrane oxygenation (ECMO) consumables occupy a critical junction between acute clinical care and intricate medical-device supply chains. These consumables are integral to life-sustaining circuits, and their availability, design, and regulatory status directly influence clinical outcomes in cardiac and respiratory support. Clinicians, hospital procurement teams, and medical device strategists increasingly view consumables not as interchangeable commodities but as components that shape therapy performance, patient safety, and total cost of care.

In recent years the ecosystem surrounding these supplies has matured, with manufacturers investing in materials science, compatibility validation, and sterile packaging innovations to reduce failure modes and improve shelf life. Meanwhile, health systems have elevated their sourcing strategies, emphasizing supplier qualification, traceability, and post-market surveillance. As a result, decision-makers must weigh technical compatibility, clinical evidence, and logistical reliability when specifying consumables for ECMO programs.

This report synthesizes clinical, regulatory, and commercial perspectives to help stakeholders understand how consumables function within broader care pathways. It aims to clarify the drivers of procurement decisions and the operational constraints that shape supply continuity, thereby equipping leaders with the context necessary to align product development, contracting, and clinical adoption strategies.

How advances in materials, interoperability, and supply chain models are reshaping clinical use and procurement priorities for ECMO consumables

The landscape for ECMO consumables is undergoing transformative shifts driven by technological refinement, clinical protocol evolution, and supply chain recalibration. Advances in polymer chemistry and surface treatments have reduced thrombogenicity and improved priming efficiency, enabling clinicians to extend safe run times and simplify circuit assembly. Concurrently, the integration of compact sensor suites and standardized connectors has improved interoperability, reducing the cognitive and procedural burden on perfusion teams and enabling faster deployment in emergency scenarios.

Clinical practice changes are also reshaping demand profiles. Expanded adoption of ECMO in community settings, greater use in nontraditional indications, and protocol-driven earlier intervention point to broader consumable requirements across adult and pediatric cohorts. At the same time, regulatory emphasis on human factors engineering and post-market traceability is prompting manufacturers to design consumables with clearer labeling, sterilization validation, and tamper-evident features.

Supply chain innovation has paralleled clinical and technological progress. Manufacturers and distributors are adopting just-in-time and vendor-managed inventory models, while advanced analytics are optimizing reorder points and minimizing stockouts. Taken together, these shifts are redefining value propositions: performance and reliability now compete alongside cost and availability as determinants of procurement choice, and industry participants must prioritize cross-functional alignment to capture emerging opportunities.

Implications of recent United States tariff adjustments on procurement strategies, supply resilience, and manufacturer localization choices in the ECMO consumables sector

The policy environment surrounding tariffs and trade measures can materially influence sourcing strategies for ECMO consumables, particularly for components with concentrated manufacturing footprints. Recent tariff adjustments in the United States have elevated the cost calculus for imported components, prompting health systems and distributors to reassess supplier portfolios and to accelerate localization efforts where feasible. These policy signals have also intensified dialogue between manufacturers and regulatory teams about qualifying alternate suppliers and securing dual-source pathways.

As a consequence, procurement teams are evaluating the trade-offs between domestic sourcing premiums and the operational risks of single-supplier dependency. Manufacturers face added pressure to demonstrate resilient supply chains, which often requires qualifying secondary manufacturing sites, increasing inventory buffers, or investing in regional production capabilities. At the same time, distributors and hospital networks are exploring longer-term contracting mechanisms and demand-aggregation strategies to dilute tariff impacts across larger purchasing volumes.

Importantly, tariff-driven cost pass-throughs can influence clinical adoption timelines for elective or non-urgent indications, but they also catalyze strategic responses that strengthen overall supply continuity. Stakeholders should anticipate ongoing policy flux and embed scenario planning into sourcing strategies to maintain clinical readiness while managing cost pressures and compliance requirements.

A multidimensional segmentation analysis that illuminates how product classes, clinical applications, support modes, and end-user types drive consumable selection and supply strategies

Segment-level dynamics reveal differentiated drivers and constraints across product categories, patient groups, modes of support, and end-user types that shape demand characteristics and procurement behavior. Product segmentation encompasses Cannula, Heat Exchanger, Oxygenator, Pump Head, and Tubing Set, with specific attention to the Pump Head category subdivided into Centrifugal Pump Head and Roller Pump Head; each product class demands distinct validation, inventory strategies, and clinical training considerations. Application segmentation across Adult, Neonatal, and Pediatric cohorts imposes unique size, flow, and blood-contact material requirements that influence SKU complexity and sterility protocols.

Mode of support segmentation differentiates Venoarterial ECMO from Venovenous ECMO, and each mode introduces particular component stressors and monitoring needs that inform selection criteria for oxygenators and pump heads. End-user segmentation separates Hospitals and Specialty Clinics, with Hospitals further classified as Government Hospitals and Private Hospitals, and Government Hospitals subdivided into Academic Medical Centers and Community Hospitals; these categories exhibit diverging procurement mandates, contracting cycles, and clinical capabilities, which in turn affect purchasing lead times and product adoption thresholds.

Understanding how these segment dimensions intersect is essential for manufacturers and distributors seeking to prioritize investments, align clinical evidence generation with target users, and design inventory strategies that respect both clinical performance requirements and operational economics.

Regional strategic priorities for manufacturing, regulatory alignment, and distribution that determine access pathways and clinical adoption across global healthcare ecosystems

Regional dynamics significantly influence manufacturing footprints, regulatory pathways, and distribution models for ECMO consumables, and they create distinct strategic priorities for commercial teams. In the Americas, centralized hospital systems and regional group purchasing organizations often negotiate long-term contracts and emphasize scalability for adult care, while also supporting neonatal and pediatric specialty centers through targeted distribution networks. Europe, Middle East & Africa features diverse regulatory frameworks and reimbursement environments that require manufacturers to tailor regulatory dossiers and local registration strategies, with particular attention to localized sterilization and labeling conventions.

Asia-Pacific exhibits a heterogeneous mix of advanced tertiary hospitals and rapidly expanding community care capabilities, which creates simultaneous demand for high-performance consumables and cost-effective variants; manufacturers often adopt tiered product strategies to serve both premium centers and high-volume regional hospitals. Logistics, customs processes, and cold-chain capabilities differ across these regions, so companies must build flexible distribution channels and localized after-sales support to maintain uptime and clinician confidence.

Taken together, regional considerations should guide product roadmaps, clinical evidence generation, and go-to-market models. Companies that adapt regulatory strategies and supply operations to regional nuances will more effectively manage time-to-market and post-market surveillance obligations while serving diverse clinical ecosystems.

Key competitive and partnership trends that shape differentiation through clinical integration, aftermarket services, and resilient distribution models

Competitive dynamics among suppliers of ECMO consumables increasingly hinge on innovation portfolios, service models, and strategic partnerships rather than on commodity pricing alone. Leading firms emphasize incremental material improvements, connector standardization, and integrated monitoring capabilities to differentiate on clinical usability and to reduce procedural errors. At the same time, companies are investing in in-service training programs, virtual simulation modules, and clinical advisory boards to accelerate adoption and to build high-confidence user communities.

Partnership activity is another salient trend: manufacturers collaborate with clinical centers to validate new designs and with logistics providers to develop resilient distribution networks that support critical-care uptime. Aftermarket services, including certified reprocessing programs where regulatory frameworks permit, and extended warranty or rapid-replacement agreements, are becoming important levers to lock in long-term relationships with high-volume hospital systems.

Strategic acquirers and investors are also watching for companies that combine robust clinical evidence with scalable manufacturing capabilities, as these attributes reduce adoption friction and ease hospital credentialing. For competitive planning, companies should prioritize capabilities that increase the total cost of switching and that deepen clinical integration, such as proprietary connector systems, validated clinical protocols, and comprehensive training infrastructures.

Actionable strategic priorities for manufacturers and health systems to enhance resilience, clinical adoption, and revenue sustainability in the ECMO consumables market

Industry leaders should pursue a balanced set of tactical and strategic initiatives to secure long-term positioning in the ECMO consumables space. First, invest in dual-source manufacturing strategies and localized production where regulatory and economic conditions support regionalization; this reduces exposure to tariff and logistics shocks and shortens replenishment cycles. Second, prioritize human factors and interoperability in product design so that devices integrate seamlessly into diverse perfusion workflows, reducing training burdens and procedural variation.

Third, develop comprehensive clinical validation plans that pair objective performance metrics with real-world use evidence; publish peer-reviewed outcomes to accelerate trust among clinicians and purchasing committees. Fourth, expand service offerings beyond product delivery by providing certified training, rapid-response replacement programs, and data-enabled inventory management to increase switching costs and improve uptime. Fifth, negotiate multi-year supply agreements with clear escalation and continuity clauses to stabilize demand and to enable capital investments in capacity.

Finally, maintain active policy engagement and scenario planning around trade measures and regulatory changes. By combining operational resilience, clinical partnerships, and service-oriented commercialization, industry leaders can convert uncertainty into competitive advantage and deliver measurable improvements in patient care pathways.

A rigorous mixed-methods research approach combining expert interviews, device validation, and supply-chain mapping to ensure reliable and actionable strategic insights

This research employed a mixed-methods approach that integrated primary stakeholder interviews, targeted device analysis, and secondary-source triangulation to produce robust, evidence-based insights. Primary inputs included structured interviews with perfusionists, critical-care physicians, hospital procurement leaders, and regulatory specialists to capture on-the-ground priorities and operational constraints. Device-level assessments incorporated materials evaluation, connector compatibility reviews, and usability testing to compare performance attributes across representative consumable categories.

Secondary research drew on peer-reviewed clinical literature, regulatory databases, and publicly available supplier documentation to validate technology trends and to contextualize policy impacts. Quantitative supply-chain mapping used shipment and customs data where permitted, combined with distributor network analysis to identify concentration risks and lead-time sensitivities. All inputs were cross-validated through a triangulation process to minimize bias and to ensure consistency between clinical practice and commercial realities.

The study also acknowledges limitations: proprietary contract terms and confidential supplier arrangements can obscure certain pricing and inventory behaviors, and rapid regulatory changes may affect time-sensitive compliance requirements. To mitigate these constraints, the methodology incorporated scenario analysis and sensitivity testing to highlight robust strategic options under varying market conditions.

Synthesis of strategic imperatives showing how clinical performance, supply resilience, and commercialization strategies determine leadership in ECMO consumables

In conclusion, ECMO consumables are central to contemporary critical care pathways and demand a coordinated response from manufacturers, distributors, and health systems to meet evolving clinical, regulatory, and logistical expectations. Technological improvements and interoperability standards are enhancing clinical usability, while tariff and trade dynamics are reshaping sourcing strategies and regional production priorities. Segment-specific considerations-spanning product types, application cohorts, modes of support, and end-user categories-underscore the importance of targeted evidence generation and differentiated go-to-market models.

Companies that invest in resilient supply chains, prioritize human factors in product design, and develop comprehensive service offerings will be better positioned to capture long-term value. Likewise, health systems that integrate scenario planning for trade policy shifts and that engage in collaborative supplier partnerships can strengthen clinical readiness and reduce operational risk. Ultimately, the intersection of clinical performance, supply reliability, and strategic commercialization will determine which organizations lead in delivering safe, effective, and readily available ECMO consumables.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. ECMO Consumables Market, by Product

  • 8.1. Cannula
  • 8.2. Heat Exchanger
  • 8.3. Oxygenator
  • 8.4. Pump Head
    • 8.4.1. Centrifugal Pump Head
    • 8.4.2. Roller Pump Head
  • 8.5. Tubing Set

9. ECMO Consumables Market, by Mode Of Support

  • 9.1. Venoarterial ECMO
  • 9.2. Venovenous ECMO

10. ECMO Consumables Market, by Application

  • 10.1. Adult
  • 10.2. Neonatal
  • 10.3. Pediatric

11. ECMO Consumables Market, by End User

  • 11.1. Hospitals
    • 11.1.1. Government Hospitals
      • 11.1.1.1. Academic Medical Centers
      • 11.1.1.2. Community Hospitals
    • 11.1.2. Private Hospitals
  • 11.2. Specialty Clinics

12. ECMO Consumables Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. ECMO Consumables Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. ECMO Consumables Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States ECMO Consumables Market

16. China ECMO Consumables Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abiomed, Inc.
  • 17.6. Asahi Kasei Medical Co., Ltd.
  • 17.7. Baxter International Inc.
  • 17.8. Becton Dickinson and Company
  • 17.9. Braile Biomedica
  • 17.10. Chalice Medical Ltd.
  • 17.11. Changzheng Medical Co., Ltd.
  • 17.12. Chinabridge (Shenzhen) Medical Technology Co., Ltd.
  • 17.13. CytoSorbents Corporation
  • 17.14. Edwards Lifesciences Corporation
  • 17.15. Eurosets S.r.l.
  • 17.16. Fresenius Medical Care AG & Co. KGaA
  • 17.17. Getinge AB
  • 17.18. Hemovent GmbH
  • 17.19. LivaNova PLC
  • 17.20. MAQUET GmbH
  • 17.21. MC3 Cardiopulmonary
  • 17.22. Medtronic plc
  • 17.23. MicroPort Scientific Corporation
  • 17.24. Neotech Products, Inc.
  • 17.25. Nihon Kohden Corporation
  • 17.26. Nipro Corporation
  • 17.27. Spectrum Medical (UK) Limited
  • 17.28. Terumo Corporation
  • 17.29. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ECMO CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ECMO CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY CENTRIFUGAL PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ROLLER PUMP HEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY TUBING SET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ECMO CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ECMO CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ECMO CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ECMO CONSUMABLES MARKET SIZE, BY PUMP HEAD, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ECMO CONSUMABLES MARKET SIZE, BY MODE OF SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ECMO CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ECMO CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ECMO CONSUMABLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ECMO CONSUMABLES MARKET SIZE, BY GOVERNMENT HOSPITALS, 2018-2032 (USD MILLION)